Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.

(Alliance News) - Genedrive PLC on Wednesday announced follow-on funding of GBP200,000 for further improvements to user experiences in rapid genetic testing environments.

Growth in Specialty and Orphan Drug Approvals: The FDA’s focus on specialty medications and orphan drugs continues to expand, with 71% of recent submissions being for specialty medications and 34% for ...

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...

Company management will be available for one-on-one meetings during the conference. If you are interested in arranging a meeting, please contact your conference representative or send an email to ...

Genedrive plc has been awarded additional funding under the DEVOTE programme, a collaboration aimed at integrating genomic technology into clinical practice. The company received approximately £1.2 ...

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the ...